Spera Pharma Co., Ltd. (Headquarters: Osaka City, Osaka Prefecture; President and CEO: Keitaro Iwaki) has received the highest-level three-star certification under the 'Osaka City Leading Company for Women's Advancement' certification program.
Since obtaining the two-star certification in 2024, the company has continuously introduced new initiatives and strengthened institutional frameworks to further promote women's active participation, leading to this achievement.
About the 'Osaka City Leading Company for Women's Advancement'
The 'Osaka City Leading Company for Women's Advancement' is a certification program launched by Osaka City in 2014. Beyond mere legal compliance, the city actively certifies companies and organizations that promote initiatives such as 'building organizations where motivated women can continue to thrive,' 'supporting work-life balance,' and 'encouraging men's participation in household responsibilities.' By certifying these entities according to established criteria, the city aims to raise public awareness and encourage broader adoption of such practices.
Certification levels are indicated by stars, reflecting the stage of progress in women's advancement initiatives. The one-star certification is awarded to organizations with foundational systems in place, while the two-star certification recognizes those with both systems and proven results. Due to the increasing number of companies advancing their efforts, a new three-star certification was introduced in April 2022 (Reiwa 4) to recognize organizations demonstrating the most advanced and impactful initiatives, thereby enhancing the program's visibility and social recognition.
Company Overview: Spera Pharma Co., Ltd.
Company Name: Spera Pharma Co., Ltd. Headquarters: 2-17-85 Juso-hommachi, Yodogawa-ku, Osaka City, Osaka Prefecture (Located within Takeda Pharmaceutical Company's Osaka Factory) Representative: President and CEO Keitaro Iwaki Founded: April 20, 2017 (Heisei 29) URL: https://www.spera-pharma.co.jp/ Business: Contract research, development, and manufacturing of pharmaceuticals (CMC services)
[Inquiries regarding this announcement]
Spera Pharma Co., Ltd. Inquiry Form
https://www.spera-pharma.co.jp/inquiry/
FACT BOX
- Source: PR TIMES
- Category: News